SCHEMBL30053701

SCHEMBL30053701

C=C(OCC)c1ncc(Br)cc1[N+](=O)[O-]

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.40
▸ GAA P10253 2/20 0.36
▸ SMN1; SMN2 Q16637 5/20 0.36
▸ MAPT P10636 5/20 0.35
▸ L3MBTL1 Q9Y468 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ LMNA P02545 3/20 0.35
▸ POLB P06746 2/20 0.35
▸ MITF O75030 2/20 0.35
▸ GALR2 O43603 1/20 0.35
▸ HSP90AA1 P07900 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ XBP1 P17861 1/20 0.35
▸ CCR6 P51684 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28419039 1.00 ALDH1A1 (0.40) ALDH1A1GAASMN1; SMN2MAPTL3MBTL1
SCHEMBL30418856 0.80 CYP1A2 (0.38) ALDH1A1GAASMN1; SMN2MAPTL3MBTL1
SCHEMBL25186795 0.80 CYP1A2 (0.38) ALDH1A1GAASMN1; SMN2MAPTL3MBTL1
SCHEMBL31310325 0.78 MAPT (0.45) ALDH1A1SMN1; SMN2MAPTKMT2APOLB
SCHEMBL18988773 0.76 ALDH1A1 (0.37) ALDH1A1GAASMN1; SMN2MAPTL3MBTL1
SCHEMBL29060088 0.76 MAPT (0.42) ALDH1A1GAASMN1; SMN2MAPTL3MBTL1
SCHEMBL3382130 0.75 RAB9A (0.50) ALDH1A1SMN1; SMN2MAPTL3MBTL1KMT2A
SCHEMBL1621780 0.75 ALDH1A1 (0.47) ALDH1A1GAASMN1; SMN2MAPTL3MBTL1
SCHEMBL30468543 0.75 ALDH1A1 (0.47) ALDH1A1GAASMN1; SMN2MAPTL3MBTL1
SCHEMBL14108033 0.75 MAPT (0.40) ALDH1A1GAASMN1; SMN2MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111356695-B Novel tricyclic compounds 北京加科思新药研发有限公司 2022-12-30 — — CN disclosed
Send feedback